Skip to main content
. 2022 Mar 11;42(3):439–445. doi: 10.19852/j.cnki.jtcm.20220311.003

Figure 3. Changes in NT-proBNP before and after treatment in the 2 groups.

Figure 3

The CO group routinely treated with albumin, dopamine, hydrochlorothiazide and other drugs. The OB group received Zhuling decoction for at least 7 d on the basis of CO group. The median NT-proBNP was 8060 ng/L pretreatment and 4000 ng/L posttreatment in the OB group. Those in the CO group were 5690 and 4945 ng/L, respectively. NT-proBNP improved in both groups, with a greater improvement in the OB group (P < 0.001). NT-proBNP: N-terminal pro-B type natriuretic peptide. CO: control group (n = 48); OB: observation group (n = 48).